The evolving role of pharma on social media

Pharma companies are increasingly active on Twitter around medical meetings, but risk crowding out other conversations from independent medical experts with the ‘noise’ of industry tweets. In an Expert View piece, Annie Sullivan, director of corporate social media at Anglo-Swedish pharma major AstraZeneca (LSE: AZN), discusses the company’s novel approach of being 'a better social media citizen' and how its adoption of this strategy at the ASCO Annual Meeting in 2017 may help evolve the role of pharma on social media.